S-amlodipine+Chlorthalidone vs S-amlodipine+Telmisartan in Hypertension
Status:
Unknown status
Trial end date:
2018-03-31
Target enrollment:
Participant gender:
Summary
Evaluation of the Efficacy and Safety of S-amlodipine+Chlorthalidone Combination Therapy and
S-amlodipine+Telmisartan Combination Therapy in Hypertensive Patients Inadequately Controlled
With CCB(Calcium Channel Blocker) Monotherapy